MONDAY, April 2, 2018 (HealthDay News) -- Young men who survive testicular cancer may need to worry about more than a return of their disease: A new study suggests they also face greater heart risks down the road.

"The overarching goal of our study is to implement early interventions in order to reduce the risk of heart disease," said researcher Dr. Mohammad Abu Zaid. An assistant professor of medicine at Indiana University's Cancer Center, he made his remarks in a news release from the National Comprehensive Cancer Network (NCCN).

Dr. Timothy Gilligan chairs the NCCN Guidelines Panel on Testicular Cancer. He explained that "for testicular cancer survivors, as with most cancer survivors, the medical concerns don't end with remission."

In the study, Abu Zaid and his colleagues analyzed 486 testicular cancer survivors who were treated with platinum-based chemotherapy. The investigators found that these patients had higher-than-normal rates of heart disease risk factors.

"At this time, there are no criteria for determining what exactly causes metabolic syndrome in cancer survivors. Developing those criteria requires long-term follow up of cancer survivors," Abu Zaid said.

"This will help us understand which risk factors are more likely to lead to heart disease for this particular population," he added.

The researchers said health care providers should screen and treat testicular cancer survivors for heart disease risk factors and urge them to adopt healthy lifestyle habits, such as regular exercise and not smoking.

The study was published online recently in the Journal of the National Comprehensive Cancer Network.